These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 24974817)

  • 1. No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38.
    Chew EY; Klein ML; Clemons TE; Agrón E; Ratnapriya R; Edwards AO; Fritsche LG; Swaroop A; Abecasis GR;
    Ophthalmology; 2014 Nov; 121(11):2173-80. PubMed ID: 24974817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration.
    Awh CC; Lane AM; Hawken S; Zanke B; Kim IK
    Ophthalmology; 2013 Nov; 120(11):2317-23. PubMed ID: 23972322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.
    van Asten F; Chiu CY; Agrón E; Clemons TE; Ratnapriya R; Swaroop A; Klein ML; Fan R; Chew EY;
    Ophthalmology; 2019 Nov; 126(11):1541-1548. PubMed ID: 31358387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration.
    Klein ML; Francis PJ; Rosner B; Reynolds R; Hamon SC; Schultz DW; Ott J; Seddon JM
    Ophthalmology; 2008 Jun; 115(6):1019-25. PubMed ID: 18423869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study.
    Awh CC; Hawken S; Zanke BW
    Ophthalmology; 2015 Jan; 122(1):162-9. PubMed ID: 25200399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits, Potential Harms, and Optimal Use of Nutritional Supplementation for Preventing Progression of Age-Related Macular Degeneration.
    Rojas-Fernandez CH; Tyber K
    Ann Pharmacother; 2017 Mar; 51(3):264-270. PubMed ID: 27866147
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Vavvas DG; Small KW; Awh CC; Zanke BW; Tibshirani RJ; Kustra R
    Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E696-E704. PubMed ID: 29311295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to AREDS supplements according to genetic factors: survival analysis approach using the eye as the unit of analysis.
    Seddon JM; Silver RE; Rosner B
    Br J Ophthalmol; 2016 Dec; 100(12):1731-1737. PubMed ID: 27471039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
    Evans JR; Lawrenson JG
    Cochrane Database Syst Rev; 2023 Sep; 9(9):CD000254. PubMed ID: 37702300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Polymorphisms of CFH and ARMS2 Do Not Predict Response to Antioxidants and Zinc in Patients with Age-Related Macular Degeneration: Independent Statistical Evaluations of Data from the Age-Related Eye Disease Study.
    Assel MJ; Li F; Wang Y; Allen AS; Baggerly KA; Vickers AJ
    Ophthalmology; 2018 Mar; 125(3):391-397. PubMed ID: 29032853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARMS2 increases the risk of early and late age-related macular degeneration in the European Eye Study.
    Chakravarthy U; McKay GJ; de Jong PT; Rahu M; Seland J; Soubrane G; Tomazzoli L; Topouzis F; Vingerling JR; Vioque J; Young IS; Sofat R; Hingorani AD; Fletcher AE
    Ophthalmology; 2013 Feb; 120(2):342-8. PubMed ID: 23098369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.
    Age-Related Eye Disease Study Research Group
    Arch Ophthalmol; 2001 Oct; 119(10):1417-36. PubMed ID: 11594942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An association of neovascular age-related macular degeneration with polymorphisms of CFH, ARMS2, HTRA1 and C3 genes in Czech population.
    Matušková V; Zeman T; Ewerlingová L; Hlinomazová Z; Souček J; Vlková E; Goswami N; Balcar VJ; Šerý O
    Acta Ophthalmol; 2020 Sep; 98(6):e691-e699. PubMed ID: 31970928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14.
    van Asten F; Simmons M; Singhal A; Keenan TD; Ratnapriya R; Agrón E; Clemons TE; Swaroop A; Lu Z; Chew EY;
    Ophthalmology; 2018 Apr; 125(4):559-568. PubMed ID: 29096998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein and CFH, ARMS2/HTRA1 gene variants are independently associated with risk of macular degeneration.
    Seddon JM; Gensler G; Rosner B
    Ophthalmology; 2010 Aug; 117(8):1560-6. PubMed ID: 20346514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extramacular drusen are highly associated with age-related macular degeneration, but not with CFH and ARMS2 genotypes.
    Ersoy L; Schick T; de Graft D; Felsch M; Hoyng CB; den Hollander AI; Kirchhof B; Fauser S; Liakopoulos S
    Br J Ophthalmol; 2016 Aug; 100(8):1047-51. PubMed ID: 26614632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.
    Domalpally A; Agrón E; Pak JW; Keenan TD; Ferris FL; Clemons TE; Chew EY
    Ophthalmology; 2019 Dec; 126(12):1659-1666. PubMed ID: 31558345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35.
    Chew EY; Clemons TE; Agrón E; Sperduto RD; Sangiovanni JP; Kurinij N; Davis MD;
    Ophthalmology; 2013 Aug; 120(8):1604-11.e4. PubMed ID: 23582353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ARMS2 A69S Polymorphism Is Associated with Delayed Rod-Mediated Dark Adaptation in Eyes at Risk for Incident Age-Related Macular Degeneration.
    Mullins RF; McGwin G; Searcey K; Clark ME; Kennedy EL; Curcio CA; Stone EM; Owsley C
    Ophthalmology; 2019 Apr; 126(4):591-600. PubMed ID: 30389424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.
    Smailhodzic D; Klaver CC; Klevering BJ; Boon CJ; Groenewoud JM; Kirchhof B; Daha MR; den Hollander AI; Hoyng CB
    Ophthalmology; 2012 Feb; 119(2):339-46. PubMed ID: 22133792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.